Blue Bird Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Blue Bird Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $1.48B | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $1.35B | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $1.13B | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | $800.64M | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | $800.64M | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | $684.00M | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $879.22M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $1.02B | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $1.02B | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $990.60M | Dec 12, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $1.48B | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $1.35B | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $1.13B | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | $800.64M | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | $800.64M | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | $684.00M | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $879.22M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $1.02B | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $1.02B | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $990.60M | Dec 12, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Oct 3, 2015 | $307.62M | Dec 15, 2015 |
| FY2015 | Jul 4, 2015 | $262.65M | Dec 15, 2015 |
| FY2015 | Apr 4, 2015 | $183.02M | Dec 15, 2015 |
| FY2015 | Jan 3, 2015 | $165.83M | Dec 15, 2015 |
| FY2015 | Sep 27, 2014 | $273.74M | Dec 15, 2015 |
| FY2015 | Jun 28, 2014 | $240.33M | Dec 15, 2015 |
| FY2015 | Mar 29, 2014 | $195.67M | Dec 15, 2015 |
| FY2015 | Dec 28, 2013 | $145.99M | Dec 15, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $303.51M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $256.16M | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $138.85M | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | $36.55M | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | $36.55M | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | $72.14M | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $96.20M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $133.47M | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $121.99M | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $127.37M | Dec 12, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $127.72M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $105.55M | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $23.81M | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | ($45.76M) | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | ($45.76M) | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | ($289.0K) | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $12.19M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $24.30M | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $30.82M | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $28.80M | Dec 12, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $167.17M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $139.33M | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $51.66M | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | ($40.70M) | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | ($40.70M) | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | $6.52M | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $21.99M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $43.83M | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $35.08M | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $59.53M | Dec 12, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $15.20M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $9.40M | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $6.60M | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | $6.10M | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | $6.10M | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | $5.20M | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $6.40M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $11.50M | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $8.50M | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $7.40M | Dec 12, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $136.35M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $116.83M | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $87.19M | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | $77.25M | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | $77.25M | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | $65.62M | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $74.21M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $89.64M | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $86.91M | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $67.84M | Dec 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $176.21M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $111.11M | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | $119.93M | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | ($24.44M) | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | ($24.44M) | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | ($54.24M) | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | $3.46M | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | $55.71M | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | $48.35M | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | $47.64M | Dec 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $625.26M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $524.89M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $417.77M | Nov 25, 2024 |
| FY2023 | Oct 1, 2022 | $366.13M | Dec 11, 2023 |
| FY2022 | Oct 2, 2021 | $356.02M | Dec 12, 2022 |
| FY2021 | Oct 3, 2020 | $317.42M | Dec 15, 2021 |
| FY2020 | Sep 28, 2019 | $365.41M | Dec 17, 2020 |
| FY2019 | Sep 29, 2018 | $307.43M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $295.82M | Dec 12, 2018 |
| FY2017 | Oct 1, 2016 | $277.87M | Dec 8, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $8.41M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $323.0K | Feb 27, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $255.42M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $159.56M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $40.00M | Nov 25, 2024 |
| FY2023 | Oct 1, 2022 | $1.38M | Dec 11, 2023 |
| FY2022 | Oct 2, 2021 | ($32.66M) | Dec 12, 2022 |
| FY2021 | Oct 3, 2020 | ($53.23M) | Dec 15, 2021 |
| FY2020 | Sep 28, 2019 | ($67.81M) | Dec 17, 2020 |
| FY2019 | Sep 29, 2018 | ($28.34M) | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | ($58.51M) | Dec 12, 2018 |
| FY2017 | Oct 1, 2016 | ($86.97M) | Dec 8, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $18.83M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $18.83M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $18.83M | Nov 25, 2024 |
| FY2023 | Oct 1, 2022 | $18.83M | Dec 11, 2023 |
| FY2022 | Oct 2, 2021 | $18.83M | Dec 12, 2022 |
| FY2021 | Oct 3, 2020 | $18.83M | Dec 15, 2021 |
| FY2020 | Sep 28, 2019 | $18.83M | Dec 17, 2020 |
| FY2019 | Sep 29, 2018 | $18.83M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $18.83M | Dec 12, 2018 |
| FY2017 | Oct 1, 2016 | $18.83M | Dec 8, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $88.19M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $0 | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | ($55.70M) | Nov 25, 2024 |
| FY2023 | Oct 1, 2022 | ($79.51M) | Dec 11, 2023 |
| FY2022 | Oct 2, 2021 | ($33.75M) | Dec 12, 2022 |
| FY2021 | Oct 3, 2020 | ($33.46M) | Dec 15, 2021 |
| FY2020 | Sep 28, 2019 | ($45.65M) | Dec 17, 2020 |
| FY2019 | Sep 29, 2018 | ($69.24M) | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | ($100.06M) | Dec 12, 2018 |
| FY2017 | Oct 1, 2016 | ($128.86M) | Dec 8, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $229.31M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | $127.69M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | $78.99M | Nov 25, 2024 |
| FY2023 | Oct 1, 2022 | $10.48M | Dec 11, 2023 |
| FY2022 | Oct 2, 2021 | $11.71M | Dec 12, 2022 |
| FY2021 | Oct 3, 2020 | $44.51M | Dec 15, 2021 |
| FY2020 | Sep 28, 2019 | $70.96M | Dec 17, 2020 |
| FY2019 | Sep 29, 2018 | $60.26M | Dec 12, 2019 |
| FY2019 | Sep 30, 2017 | $62.62M | Dec 12, 2019 |
| FY2018 | Oct 1, 2016 | $52.31M | Dec 12, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 4 | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | 3 | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | 0 | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | (1) | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | (1) | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | 0 | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | 0 | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | 0 | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | 1 | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | 0 | Dec 12, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 3 | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | 3 | Nov 24, 2025 |
| FY2023 | Sep 30, 2023 | 0 | Dec 11, 2023 |
| FY2023 | Oct 1, 2022 | (1) | Dec 11, 2023 |
| FY2024 | Sep 30, 2022 | (1) | Nov 25, 2024 |
| FY2023 | Oct 2, 2021 | 0 | Dec 11, 2023 |
| FY2022 | Oct 3, 2020 | 0 | Dec 12, 2022 |
| FY2021 | Sep 28, 2019 | 0 | Dec 15, 2021 |
| FY2020 | Sep 29, 2018 | 1 | Dec 17, 2020 |
| FY2019 | Sep 30, 2017 | 0 | Dec 12, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 31.88M | Nov 24, 2025 |
| FY2025 | Sep 28, 2024 | 32.27M | Nov 24, 2025 |
| FY2024 | Sep 30, 2023 | 32.17M | Nov 25, 2024 |
| FY2023 | Oct 1, 2022 | 32.02M | Dec 11, 2023 |
| FY2022 | Oct 2, 2021 | 27.21M | Dec 12, 2022 |
| FY2021 | Oct 3, 2020 | 27.05M | Dec 15, 2021 |
| FY2020 | Sep 28, 2019 | 26.48M | Dec 17, 2020 |
| FY2019 | Sep 29, 2018 | 27.26M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | 23.74M | Dec 12, 2018 |
| FY2017 | Oct 1, 2016 | 22.52M | Dec 8, 2017 |